|Written by Rob Goldman|
Look, there is a reason gun sales are surging and the more gun control advocates make noise or these horrific events occur, the more gun sales will climb. Thus, it is a no-brainer town these stocks, regardless of their big performance this year, are going to move higher. See what to expect from these stocks and their surprisingly reasonable valuations.
Each year around this time, year-end selling occurs in stocks that have been poor or disappointing performers over the previous 6-12 months. The heavy and steady selling in these securities typically results in unique oversold opportunities toward the end of the year, especially in small cap stocks. Moreover, history illustrates that many of one year’s big losers tend to be strong performers during the early part of the following year. This week’s candidate is under major accumulation, has a series of very positive events in its sights, and could grow by 40% by early next year.
IT’S A DIFFERENT BATTLE TODAY
Seventy-four years ago today, Japan attacked Pearl Harbor in a surprise event that thrust the U.S. into WWII. It is amazing to think that the youngest survivor of that event is 92 years old. Our hats are off to those that gave their lives and those that survived and were a part of what is considered “the greatest generation.”
Unlike the battles of those times and wars years later, we are now engaged in the other side of the war on terror. Much as many wish to ignore the unmistakable signs, such as President Obama, it cannot be denied an longer. After all, when Obama has only his third evening press conference from the Oval Office to state that we have entered a new phase here, it is for real.
When the events of last week in California and in England over the weekend referred to as terror events, we must concede that something has to give or change.
No longer are attacks prepared by major armed forces, or even smallish cells/groups alone. They can be small groups or lone wolves that attack at will in an uncoordinated fashion here in the U.S. and with much planning abroad.
These events have prompted more discussion regarding greater gun control and the lessening of current guidelines. The government and our citizenry are locked in a conflict over what steps to take. There is a reason gun sales are surging and the more gun control advocates make noise or these horrific events occur, the more gun sales will climb. Thus, it is a no-brainer town these stocks, regardless of their YTD performance, will move higher.
The Stock Market Today
Although it tried to break through the 1200 mark earlier this month, until Friday, the Russell 2000 Index had not broken above the 1200 level since August 19th, the day before all hell broke loose. All of the preaching that small stocks are coming back has come to fruition and the time is right to feel comfortable enough to have meaningful exposure in this category. After all, not only is the index a hair from its 2014 close, but just shy of its 200 DMA, an important technical measure. Our Thanksgiving report of last week is a good source of ideas.
Investors will be hearing a lot about how poor physical store Black Friday sales were (on a relative basis) and online was pretty good. Of course, that could be largely determined by Cyber Monday where a lot of the big box and retail stores are ready to sell us their wares at huge discounts. I would recommend paying close attention to the fact that consumers were buying fewer items or were targeted in their purchases in the real world and more broad in their buying habits online. Data on this front could tell the true tale of the start of holiday shopping.
We believe that crowds were generally smaller and apparel inventory high causing the Macys (NYSE—M) of the world to offer big-ass discounts. Therefore, be wary of the stocks you buy in this space until more clarity occurs mid-week.
If you are older than 40, the brand name Avon may make you wax nostalgic as you remember your mother or grandmother buy Avon Products (NYSE—AVP—$4.22), or even picture the Avon lady that sold them door-to-door years ago. For the uninitiated, Avon bills itself as is the company that for more than 125 years has stood for beauty, innovation, and optimism for women. With a projected $7 billion in annual revenue in 2015, Avon has products that are sold through 6 million active, independent Avon Sales Representatives worldwide. Avon products include color cosmetics, skincare, fragrance, and fashion and home, featuring well-recognized brand names.
The stock is down a whopping 53% year-to-date as revenue and EPS have been crushed this year. Sales are forecasted to drop by 19% with EPS generation of a paltry $0.14 as compared with $0.75 in 2014. The good news is that management appears to have stemmed the bleeding as of 3Q15 and Wall Street has revised its EPS expectations to $0.33 for 2016, more than double the forecast for 2015. Management is hosting an investor day on January 21, 2016 which is likely to spark renewed confidence and interest in the stock and likely coincide with a reduction in its annual dividend, which has long been expected and would be lauded by Wall Street.
Plus, just last week, AVP announced it is selling its North American business to a private equity firm. While some believe it can unlock value, other, vocal, activist investors are slamming it, citing the price as too low. Since then, the stock has risen on strong volume and could result in a higher price not just for the unit but for the company as a whole. I think the stock could trade well above the $5 level by early next year, which represents 15x—18x the 2016 EPS estimate, and a 40%+ return.
Great info, insights, and hard-hitting stories make up this week’s Say What? feature...
International Business Times
Might be a bit alarmist but very useful perspective.
Looks more pain for oil producing countries and companies.
The New York Post
Funny stuff even if it isn’t true.
The “T” word.
Beware the run on shipwreck stocks.
Just the Stats!
AAII Sentiment Survey (figures rounded)
Huh? In the AAII survey half of the respondents are Neutral while nearly half of the Ticker Sense bloggers are bullish. What gives? Considering we are entering an historically strong period, we agree with the latter rather than the former. Moreover, time will likely bear this out as well.
1498 Reisterstown Road, Suite 286 Baltimore Maryland 21208 Phone: 410.609.7100
Launched in May 2010, The Goldman Guide is a free weekly publication of Goldman Small Cap Research and is written by Founder Rob Goldman with contributions from the GSCR contributor team. This non-sponsored investment newsletter seeks to provide investors with market, economic, political and equity-specific insights via an action-oriented, straight to the point approach. No companies mentioned in this newsletter are current sponsored research clients of the Company or its parent, unless noted, With some exceptions, all companies or investment ideas mentioned in this publication are publicly traded stocks listed either on the NYSE or the NASDAQ. Goldman Small Cap Research members and contributors’ bios, certifications, and experience can be found on our website: www.goldmanresearch.com
This newsletter was prepared for informational purposes only. Goldman Small Cap Research, (a division of Two Triangle Consulting Group, LLC) produces non-sponsored and sponsored (paid) investment research. Goldman Small Cap Research is not affiliated in any way with Goldman Sachs & Co.
The Firm’s non-sponsored research publications category, Select Research, reflects the Firm’s internally generated stock ideas, along with economic, industry and market outlooks. In virtually all cases, stocks mentioned in Select Research offerings are listed on the NYSE or the NASDAQ. Publications in this category include the weekly newsletter The Goldman Guide, Market Monitor blogs, Special Reports, and premium products such as The 30-30 Report. Goldman Small Cap Research analysts are neither long nor short stocks mentioned in this newsletter.
Opportunity Research reports, updates and Microcap Hot Topics articles reflect sponsored (paid) research but can also include non-sponsored microcap research ideas that typically carry greater risks than those stocks covered in Select Research category. It is important to note that while we may track performance separately, we utilize many of the same coverage criteria in determining coverage of all stocks in both research formats. Please view the company’s individual disclosures for each engagement, which can be found in company-specific Opportunity Research reports, updates and articles.
Goldman Small Cap Research has not been compensated for any content in this issue.
All information contained in this newsletter and in our reports were provided by the companies mentioned via news releases, filings, and their websites or generated from our own due diligence. Economic, market data and charts are provided by a variety of sources and are cited upon publication. Stock performance data and information are derived from Yahoo! Finance and other websites or sources, as noted. Our analysts are responsible only to the public, and are paid in advance to eliminate pecuniary interests, retain editorial control, and ensure independence.
The information used and statements of fact made have been obtained from sources considered reliable but we neither guarantee nor represent the completeness or accuracy. Goldman Small Cap Research did not make an independent investigation or inquiry as to the accuracy of any information provided by the Company, other firms, or other financial news outlets. Goldman Small Cap Research relied solely upon information provided by companies through filings, press releases, presentations, and through its own internal due diligence for accuracy and completeness. Such information and the opinions expressed are subject to change without notice. A Goldman Small Cap Research report, update, article, blog, note, or newsletter is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. This newsletter does not take into account the investment objectives, financial situation, or particular needs of any particular person. This newsletter does not provide all information material to an investor’s decision about whether or not to make any investment. Any discussion of risks in this presentation is not a disclosure of all risks or a complete discussion of the risks mentioned. Neither Goldman Small Cap Research, nor its parent, is registered as a securities broker-dealer or an investment adviser with the FINRA or with any state securities regulatory authority. Statements herein may contain forward-looking statements and are subject to significant risks and uncertainties affecting results.
Separate from the factual content of our articles about the company featured in this newsletter, we may from time to time include our own opinions about the companies profiled herein, their businesses, markets and opportunities. Any opinions we may offer about the companies are solely our own, and are made in reliance upon our rights under the First Amendment to the U.S. Constitution, and are provided solely for the general opinionated discussion of our readers. Our opinions should not be considered to be complete, precise, accurate, or current investment advice. Such information and the opinions expressed are subject to change without notice.
ALL INFORMATION IN THIS REPORT IS PROVIDED “AS IS” WITHOUT WARRANTIES, EXPRESSED OR IMPLIED, OR REPRESENTATIONS OF ANY KIND. TO THE FULLEST EXTENT PERMISSIBLE UNDER APPLICABLE LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE FOR THE QUALITY, ACCURACY, COMPLETENESS, RELIABILITY OR TIMELINESS OF THIS INFORMATION, OR FOR ANY DIRECT, INDIRECT, CONSEQUENTIAL, INCIDENTAL, SPECIAL OR PUNITIVE DAMAGES THAT MAY ARISE OUT OF THE USE OF THIS INFORMATION BY YOU OR ANYONE ELSE (INCLUDING, BUT NOT LIMITED TO, LOST PROFITS, LOSS OF OPPORTUNITIES, TRADING LOSSES, AND DAMAGES THAT MAY RESULT FROM ANY INACCURACY OR INCOMPLETENESS OF THIS INFORMATION). TO THE FULLEST EXTENT PERMITTED BY LAW, TWO TRIANGLE CONSULTING GROUP, LLC WILL NOT BE LIABLE TO YOU OR ANYONE ELSE UNDER ANY TORT, CONTRACT, NEGLIGENCE, STRICT LIABILITY, PRODUCTS LIABILITY, OR OTHER THEORY WITH RESPECT TO THIS PRESENTATION OF INFORMATION.
For more information, visit our Disclaimer: www.goldmanresearch.com.